Full Coverage
Bristol-Myers Squibb to Acquire Celgene for About $74 Billion
By Aisha Al-Muslim
Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge
By Berkeley Lovelace & Berkeley Lovelace Jr.
Bristol-Myers to Buy Celgene in $74 Billion Cancer-Drug Bet
By Rebecca Spalding & Cynthia Koons
Bristol-Myers to Acquire Celgene in Deal Worth $74 Billion (Published 2019)
By Katie Thomas & Tiffany Hsu
Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
By Michael Erman & Ankur Banerjee
Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies
By Berkeley Lovelace, Angelica Peebles & Berkeley Lovelace Jr.